- Home
- ATAI vs FCT Comparison
ATAI vs FCT Comparison
Compare ATAI & FCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- FCT
- Stock Information
- Founded
- ATAI 2018
- FCT 2004
- Country
- ATAI Germany
- FCT United States
- Employees
- ATAI N/A
- FCT N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- FCT Finance Companies
- Sector
- ATAI Health Care
- FCT Finance
- Exchange
- ATAI Nasdaq
- FCT Nasdaq
- Market Cap
- ATAI 282.6M
- FCT 255.2M
- IPO Year
- ATAI 2021
- FCT N/A
- Fundamental
- Price
- ATAI $1.41
- FCT $9.84
- Analyst Decision
- ATAI Strong Buy
- FCT
- Analyst Count
- ATAI 3
- FCT 0
- Target Price
- ATAI $10.50
- FCT N/A
- AVG Volume (30 Days)
- ATAI 1.4M
- FCT 106.8K
- Earning Date
- ATAI 05-19-2025
- FCT 01-01-0001
- Dividend Yield
- ATAI N/A
- FCT 11.29%
- EPS Growth
- ATAI N/A
- FCT N/A
- EPS
- ATAI N/A
- FCT N/A
- Revenue
- ATAI $308,000.00
- FCT N/A
- Revenue This Year
- ATAI $65.58
- FCT N/A
- Revenue Next Year
- ATAI N/A
- FCT N/A
- P/E Ratio
- ATAI N/A
- FCT N/A
- Revenue Growth
- ATAI N/A
- FCT N/A
- 52 Week Low
- ATAI $1.03
- FCT $9.45
- 52 Week High
- ATAI $2.57
- FCT $10.42
- Technical
- Relative Strength Index (RSI)
- ATAI 44.57
- FCT 48.99
- Support Level
- ATAI $1.36
- FCT $9.81
- Resistance Level
- ATAI $1.54
- FCT $9.98
- Average True Range (ATR)
- ATAI 0.09
- FCT 0.10
- MACD
- ATAI -0.00
- FCT 0.02
- Stochastic Oscillator
- ATAI 0.00
- FCT 61.11
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
About FCT First Trust Senior Floating Rate Income Fund II of Beneficial Interest
First Trust Senior Floating Rate Income Fund II is the United States based diversified, closed-end management investment company. Its investment objective is to seek a high level of current income. As a secondary objective, the fund attempts to preserve capital. The fund seeks to achieve the objectives by investing in a portfolio of senior floating-rate loan interests. Its portfolio of investments consists of aerospace and defense, agricultural products, broadcasting, cable and satellite, electric utilities and other sectors.